A Multicenter, Double-blind, Randomized, Placebo-controlled Trial of the β3-Adrenoceptor Agonist Solabegron for Overactive Bladder - Concepedia

Concepedia

Publication | Closed Access

A Multicenter, Double-blind, Randomized, Placebo-controlled Trial of the β3-Adrenoceptor Agonist Solabegron for Overactive Bladder

113

Citations

17

References

2012

Year

Eliot H. Ohlstein, Alexander von Keitz, Martin C. Michel

European Urology

Urological ResearchUrologyVoiding DysfunctionMedicineβ3-Adrenoceptor Agonist SolabegronPlacebo-controlled TrialPain ManagementUrogynecologyPharmacologyOveractive Bladder

References

	Year	Citations

Page 1